Function and characteristics of PINK1 in mitochondria

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Matsuda, Satoru ^a   Kitagishi, Yasuko ^a   Kobayashi, Mayumi ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL DEATH; DISEASE CONTROL; NEURODEGENERATIVE DISEASES;

CELL APOPTOSIS; CONTROL MECHANISM; MITOCHONDRIAL DYSFUNCTION; NEURODEGENERATIVE DISORDERS; PARKINSON'S DISEASE; PHOSPHATASE AND TENSIN HOMOLOGUES; SERINE PROTEASE; STEADY STATE;

MITOCHONDRIA;

MEMBRANE PROTEIN; PARKIN; PARL PROTEIN; PHOSPHATASE AND TENSIN HOMOLOGUE INDUCED KINASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RHOMBOID SERINE PROTEASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GENE SILENCING; HOMEOSTASIS; HUMAN; MITOCHONDRION; MITOPHAGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUALITY CONTROL; REVIEW; STEADY STATE;

EID: 84875488705     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/601587     Document Type: Review

References (62)

1. Nicholls D. G., Mitochondrial ion circuits. Essays in Biochemistry 2010 47 25 35
2. Novak I., Mitophagy: a complex mechanism of mitochondrial removal. Antioxidants & Redox Signaling 2012 17 5 794 802
3. 2+ and neurodegeneration. Cell Calcium 2012 52 1 73 85
4. Gandhi S., Abramov A. Y., Mechanism of oxidative stress in neurodegeneration. Oxidative Medicine and Cellular Longevity 2012 2012 11 428010 10.1155/2012/428010
5. Nakamura T., Lipton S. A., Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death & Differentiation 2011 18 9 1478 1486
6. Feng L. R., Maguire-Zeiss K. A., Gene therapy in parkinsons disease: rationale and current status. CNS Drugs 2010 24 3 177 192 2-s2.0-76949097385 10.2165/11533740-000000000-00000
7. Corti O., Lesage S., Brice A., What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiological Reviews 2011 91 4 1161 1218
8. Deas E., Plun-Favreau H., Gandhi S., Desmond H., Kjaer S., Loh S. H., Renton A. E., Harvey R. J., Whitworth A. J., Martins L. M., Abramov A. Y., Wood N. W., PINK1 cleavage at position A103 by the mitochondrial protease PARL. Human Molecular Genetics 2011 20 5 867 879 2-s2.0-79551574736 10.1093/hmg/ddq526
9. Greene A. W., Grenier K., Aguileta M. A., Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Reports 2012 13 4 378 385
10. Rochet J. C., Hay B. A., Guo M., Molecular insights into Parkinson's disease. Progress in Molecular Biology and Translational Science 2012 107 125 188
11. Kumar K. R., Djarmati-Westenberger A., Grünewald A., Genetics of Parkinson's disease. Seminars in Neurology 2011 31 5 433 440
12. Taymans J. M., Van Den Haute C., Baekelandt V., Distribution of PINK1 and LRRK2 in rat and mouse brain. Journal of Neurochemistry 2006 98 3 951 961 2-s2.0-33745917404 10.1111/j.1471-4159.2006.03919.x (Pubitemid 44051294)
13. Blackinton J. G., Anvret A., Beilina A., Olson L., Cookson M. R., Galter D., Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain Research 2007 1184 1 10 16 2-s2.0-36448932411 10.1016/j.brainres.2007.09.056 (Pubitemid 350161884)
14. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E. M., Casari G., Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Human Molecular Genetics 2005 14 22 3477 3492 2-s2.0-27944444154 10.1093/hmg/ddi377 (Pubitemid 41672130)
15. Muqit M. M. K., Abou-Sleiman P. M., Saurin A. T., Harvey K., Gandhi S., Deas E., Eaton S., Payne Smith M. D., Venner K., Matilla A., Healy D. G., Gilks W. P., Lees A. J., Holton J., Revesz T., Parker P. J., Harvey R. J., Wood N. W., Latchman D. S., Altered cleavage and localization of PINK1 to aggresomes in thepresence of proteasomal stress. Journal of Neurochemistry 2006 98 1 156 169 2-s2.0-33745068109 10.1111/j.1471-4159.2006.03845.x (Pubitemid 43882941)
16. Weihofen A., Thomas K. J., Ostaszewski B. L., Cookson M. R., Selkoe D. J., Pink1 forms a multiprotein complex with miro and milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 2009 48 9 2045 2052 2-s2.0-64549112144 10.1021/bi8019178
17. Jin S. M., Lazarou M., Wang C., Kane L. A., Narendra D. P., Youle R. J., Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. Journal of Cell Biology 2010 191 5 933 942 2-s2.0-78649685455 10.1083/jcb.201008084
18. Pilsl A., Winklhofer K. F., Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease. Acta Neuropathologica 2012 123 2 173 188
19. Pridgeon J. W., Olzmann J. A., Chin L. S., Li L., PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLOS Biology 2007 5 7, article e172
20. Plun-Favreau H., Klupsch K., Moisoi N., Gandhi S., Kjaer S., Frith D., Harvey K., Deas E., Harvey R. J., McDonald N., Wood N. W., Martins M. L., Downward J., The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nature Cell Biology 2007 9 11 1243 1252 2-s2.0-35748935851 10.1038/ncb1644 (Pubitemid 350042356)
21. Desideri E., Martins L. M., Mitochondrial stress signalling: HTRA2 and Parkinson's disease. International Journal of Cell Biology 2012 2012 6 607929 10.1155/2012/607929
22. Behbahani H., Pavlov P. F., Wiehager B., Nishimura T., Winblad B., Ankarcrona M., Association of Omi/HtrA2 with γ -secretase in mitochondria. Neurochemistry International 2010 57 6 668 675 2-s2.0-77957018009 10.1016/j.neuint.2010.08.004
23. Strauss K. M., Martins L. M., Plun-Favreau H., Marx F. P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Müller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J. B., Krüger R., Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Human Molecular Genetics 2005 14 15 2099 2111 2-s2.0-25444498785 10.1093/hmg/ddi215 (Pubitemid 41418010)
24. Yamamoto A., Cremona M. L., Rothman J. E., Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. Journal of Cell Biology 2006 172 5 719 731 2-s2.0-33644540193 10.1083/jcb.200510065
25. Michiorri S., Gelmetti V., Giarda E., Lombardi F., Romano F., Marongiu R., Nerini-Molteni S., Sale P., Vago R., Arena G., Torosantucci L., Cassina L., Russo M. A., Dallapiccola B., Valente E. M., Casari G., The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death and Differentiation 2010 17 6 962 974 2-s2.0-77952242572 10.1038/cdd.2009.200
26. Sekine S., Kanamaru Y., Koike M., Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. Journal of Biological Chemistry 2012 287 41 34635 34645
27. Gautier C. A., Kitada T., Shen J., Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2008 105 32 11364 11369 2-s2.0-49649097747 10.1073/pnas.0802076105
28. Wang H. L., Chou A. H., Wu A. S., Chen S. Y., Weng Y. H., Kao Y. C., Yeh T. H., Chu P. J., Lu C. S., PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons. Biochimica et Biophysica Acta 2011 1812 6 674 684 2-s2.0-79954616687 10.1016/j.bbadis.2011.03.007
29. Gardner P. R., Fridovich I., Quinolinate synthetase: the oxygen-sensitive site of de novo NAD(P)+ biosynthesis. Archives of Biochemistry and Biophysics 1991 284 1 106 111 2-s2.0-0026023121 10.1016/0003-9861(91)90270-S
30. Gardner P. R., Costantino G., Szabó C., Salzman A. L., Nitric oxide sensitivity of the aconitases. Journal of Biological Chemistry 1997 272 40 25071 25076 2-s2.0-0030822507 10.1074/jbc.272.40.25071 (Pubitemid 27415688)
31. Wang X., Winter D., Ashrafi G., PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011 147 4 893 906
32. Wang H. L., Chou A. H., Yeh T. H., PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiology of Disease 2007 28 2 216 226
33. Cherra S. J. III, Chu C. T., Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurology 2008 3 3 309 323 2-s2.0-44149124887 10.2217/14796708.3.3.309 (Pubitemid 351715775)
34. Cherra S. J. III, Dagda R. K., Chu C. T., Review: autophagy and neurodegeneration: survival at a cost? Neuropathology and Applied Neurobiology 2010 36 2 125 132 2-s2.0-77949881747 10.1111/j.1365-2990.2009.01062.x
35. Dagda R. K., Cherra S. J., Kulich S. M., Tandon A., Park D., Chu C. T., Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. Journal of Biological Chemistry 2009 284 20 13843 13855 2-s2.0-67649399288 10.1074/jbc.M808515200
36. Shi G., Lee J. R., Grimes D. A., Racacho L., Ye D., Yang H., Ross O. A., Farrer M., McQuibban G. A., Bulman D. E., Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Human Molecular Genetics 2011 20 10 1966 1974 2-s2.0-79955410000 10.1093/hmg/ddr077
37. Chu C. T., A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Human Molecular Genetics 2010 19 1 R28 R37 2-s2.0-77953877676 10.1093/hmg/ddq143
38. Dagda R. K., Chu C. T., Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. Journal of Bioenergetics and Biomembranes 2009 41 6 473 479 2-s2.0-76949087985 10.1007/s10863-009-9255-1
39. Xiong H., Wang D., Chen L., Yeun S. C., Ma H., Tang C., Xia K., Jiang W., Ronai Z., Zhuang X., Zhang Z., Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. Journal of Clinical Investigation 2009 119 3 650 660 2-s2.0-65649118917 10.1172/JCI37617
40. Kim Y., Park J., Kim S., Song S., Kwon S. K., Lee S. H., Kitada T., Kim J. M., Chung J., PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochemical and Biophysical Research Communications 2008 377 3 975 980 2-s2.0-56049091236 10.1016/j.bbrc.2008.10.104
41. Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. Journal of Cell Biology 2008 183 5 795 803
42. Narendra D. P., Youle R. J., Targeting mitochondrial dysfunction: role for PINK1 and parkin in mitochondrial quality control. Antioxidants and Redox Signaling 2011 14 10 1929 1938 2-s2.0-79954577302 10.1089/ars.2010.3799
43. Kathrin Lutz A., Exner N., Fett M. E., Schleke J. S., Kloos K., Lämmermann K., Brunner B., Kurz-Drexler A., Vogel F., Reichert A. S., Bouman L., Vogt-Weisenhorn D., Wurst W., Tatzelt J., Haass C., Winklhofer K. F., Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. Journal of Biological Chemistry 2009 284 34 22938 22951 2-s2.0-69249096578 10.1074/jbc.M109.035774
44. Sandebring A., Thomas K. J., Beilina A., van der Brug M., Cleland M. M., Ahmad R., Miller D. W., Zambrano I., Cowburn R. F., Behbahani H., Cedazo-Mínguez A., Cookson M. R., Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 2009 4 5 2-s2.0-66349123690 10.1371/journal.pone.0005701 e5701
45. Narendra D., Walker J. E., Youle R., Mitochondrial quality control mediated by PINK1 and Parkin: links to Parkinsonism. Cold Spring Harbor Perspectives in Biology 2012 4 11 10.1101/cshperspect.a011338
46. Gegg M. E., Schapira A. H. V., PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: implications for Parkinson disease pathogenesis. Autophagy 2011 7 2 243 245 2-s2.0-79551548511 10.4161/auto.7.2. 14332
47. Meissner C., Lorenz H., Weihofen A., Selkoe D. J., Lemberg M. K., The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. Journal of Neurochemistry 2011 117 5 856 867 2-s2.0-79955667485 10.1111/j.1471-4159.2011.07253.x
48. Okatsu K., Oka T., Iguchi M., PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nature Communications 2012 3, article 1016 10.1038/ncomms2016
49. Cookson M. R., Bandmann O., Parkinson's disease: insights from pathways. Human Molecular Genetics 2010 19 1 R21 R27 2-s2.0-77953890085 10.1093/hmg/ddq167
50. Gu G. J., Wu D., Lund H., Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease, analyzed via proximity ligation. Journal of Alzheimer's Disease 2012 33 3 699 713
51. Matenia D., Hempp C., Timm T., Eikhof A., Mandelkow E. M., Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport. Journal of Biological Chemistry 2012 287 11 8174 8186
52. Plun-Favreau H., Klupsch K., Moisoi N., Gandhi S., Kjaer S., Frith D., Harvey K., Deas E., Harvey R. J., McDonald N., Wood N. W., Martins M. L., Downward J., The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nature Cell Biology 2007 9 11 1243 1252 2-s2.0-35748935851 10.1038/ncb1644 (Pubitemid 350042356)
53. Plun-Favreau H., Gandhi S., Wood-Kaczmar A., Deas E., Yao Z., Wood N. W., What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease? Annals of the New York Academy of Sciences 2008 1147 30 36 2-s2.0-57649194934 10.1196/annals.1427.032
54. Tain L. S., Chowdhury R. B., Tao R. N., Plun-Favreau H., Moisoi N., Martins L. M., Downward J., Whitworth A. J., Tapon N., Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin. Cell Death and Differentiation 2009 16 8 1118 1125 2-s2.0-67650718212 10.1038/cdd.2009.23
55. Yun J., Cao J. H., Dodson M. W., Clark I. E., Kapahi P., Chowdhury R. B., Guo M., Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the pink1/parkin pathway in vivo. Journal of Neuroscience 2008 28 53 14500 14510 2-s2.0-58149375389 10.1523/JNEUROSCI.5141-08.2008
56. Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway: a mitochondrial quality control system? Journal of Bioenergetics and Biomembranes 2009 41 6 499 503 2-s2.0-76949092128 10.1007/s10863-009-9253-3
57. Whitworth A. J., Lee J. R., Ho V. M. W., Flick R., Chowdhury R., McQuibban G. A., Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. DMM Disease Models and Mechanisms 2008 1 2-3 168 174 2-s2.0-58149397651 10.1242/dmm.000109
58. Gautier C. A., Kitada T., Shen J., Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2008 105 11364 11369
59. Billia F., Hauck L., Konecny F., Rao V., Shen J., Mak T. W., PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proceedings of the National Academy of Sciences of the United States of America 2011 108 23 9572 9577 2-s2.0-79959344616 10.1073/pnas.1106291108
60. Liu W., Acín-Peréz R., Geghman K. D., Manfredi G., Lu B., Li C., Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proceedings of the National Academy of Sciences of the United States of America 2011 108 31 12920 12924 2-s2.0-79961233786 10.1073/pnas.1107332108
61. Koh H., Chung J., PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity. Molecules and Cells 2012 34 1 7 13 10.1007/s10059-012-0100-8
62. Santos D., Cardoso S. M., Mitochondrial dynamics and neuronal fate in Parkinson's disease. Mitochondrion 2012 12 4 428 437 10.1016/j.mito.2012.05.002